Home > News > Breaktrough in Live Bacteria Quantification With Nanosensor
October 13th, 2004
Breaktrough in Live Bacteria Quantification With Nanosensor
Abstract:
Biophage Pharma Inc. (TSX-V: BUG), a biopharmaceutical company engaged in the development of new therapeutics and clinical diagnostics based on its leading expertise in immunology and phage therapy, announced today that it has reached a significant milestone in the detection and quantification of bacteria. The continued development of the Nanosensor has enabled Biophage to detect 5 to 10 bacteria in 1 ml of liquid sample.
Source:
ccnmatthews
Bookmark:
| Related News Press |
Possible Futures
Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026
COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026
Sensors
Tiny nanosheets, big leap: A new sensor detects ethanol at ultra-low levels January 30th, 2026
From sensors to smart systems: the rise of AI-driven photonic noses January 30th, 2026
Sensors innovations for smart lithium-based batteries: advancements, opportunities, and potential challenges August 8th, 2025
Announcements
Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026
COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026
Homeland Security
The picture of health: Virginia Tech researchers enhance bioimaging and sensing with quantum photonics June 30th, 2023
Sensors developed at URI can identify threats at the molecular level: More sensitive than a dog's nose and the sensors don't get tired May 21st, 2021
Highly sensitive dopamine detector uses 2D materials August 7th, 2020
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||